manilatimes1h
Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
In the United States, ONS-5010 / LYTENAVA™ (bevacizumab-vikg) is investigational.
Mount St. Mary’s Mountaineers take on the Fairfield Stags, seek 5th straight victory
Mount St. Mary's will try to extend its four-game win streak with a victory against Fairfield. Friday's game will be the second meeting this season between the two teams.
Gonsalves leads Utah Tech against Cal Baptist after 24-point performance
Utah Tech hosts the Cal Baptist Lancers after Noa Gonsalves scored 24 points in Utah Tech's 82-75 loss to the Southern Utah Thunderbirds.
Harsh flu season has health officials worried about brain complications in children
Federal health officials are trying to tell if this year's harsh flu season led to an increase in a rare but dangerous brain ...
manilatimes17h
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a ...